Voltar
Artigo Acesso aberto Revisado por pares
BIBTEX RIS

Performance of Premarket Rapid Hepatitis C Virus Antibody Assays in 4 National Human Immunodeficiency Virus Behavioral Surveillance System Sites

2011; Oxford University Press; Volume: 53; Issue: 8 Linguagem: Inglês

10.1093/cid/cir499

ISSN

1537-6591

Autores

Bryce D. Smith, Eyasu H. Teshale, Amy Jewett, Cindy M. Weinbaum, Alan Neaigus, Holly Hagan, Samuel M. Jenness, Sharon Melville, Richard K. Burt, Hanne Thiede, Alia Al‐Tayyib, P. R. Pannala, Isa Miles, Alexandra M. Oster, Amanda Smith, Teresa Finlayson, Kristina Bowles, Elizabeth DiNenno,

Tópico(s)

HIV/AIDS drug development and treatment

Resumo

Summary: Performance characteristics of rapid assays for hepatitis C virus antibody were evaluated in 4 National HIV Behavioral Surveillance System injection drug use sites. The highest assay-specific sensitivities achieved for the Chembio, MedMira and OraSure tests were 94.0%, 78.9%, and 97.4%, respectively; the highest specificities were 97.7%, 83.3%, and 100%, respectively.

Referência(s)